BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26697914)

  • 1. Biobank Finances: A Socio-Economic Analysis and Review.
    Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
    Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainability in Biobanking: Model of Biobank Graz.
    Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
    Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
    Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
    Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nottingham Health Science Biobank: a sustainable bioresource.
    Matharoo-Ball B; Thomson BJ
    Biopreserv Biobank; 2014 Oct; 12(5):312-6. PubMed ID: 25340939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the Challenge of Financial Sustainability in Biobanking.
    Campos AH; Schreeder M; Parry-Jones A; Abdelhafiz AS; Larson D; Pruetz B; Geddes T; Salman A; Lazaris A
    Biopreserv Biobank; 2015 Dec; 13(6):387-95. PubMed ID: 26697907
    [No Abstract]   [Full Text] [Related]  

  • 7. Biobanking 3.0: evidence based and customer focused biobanking.
    Simeon-Dubach D; Watson P
    Clin Biochem; 2014 Mar; 47(4-5):300-8. PubMed ID: 24406300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next Chapter of the Taiwan Biobank: Sustainability and Perspectives.
    Lin JC; Chen LK; Hsiao WW; Fan CT; Ko ML
    Biopreserv Biobank; 2019 Apr; 17(2):189-197. PubMed ID: 30715914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost model for biobanks.
    Gonzalez-Sanchez MB; Lopez-Valeiras E; Morente MM; Fernández Lago O
    Biopreserv Biobank; 2013 Oct; 11(5):272-7. PubMed ID: 24835258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Business Planning in Biobanking: How to Implement a Tool for Sustainability.
    Ciaburri M; Napolitano M; Bravo E
    Biopreserv Biobank; 2017 Feb; 15(1):46-56. PubMed ID: 27898226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank.
    Vaught J; Rogers J; Carolin T; Compton C
    J Natl Cancer Inst Monogr; 2011; 2011(42):24-31. PubMed ID: 21672892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public biobanks: calculation and recovery of costs.
    Clément B; Yuille M; Zaltoukal K; Wichmann HE; Anton G; Parodi B; Kozera L; Bréchot C; Hofman P; Dagher G;
    Sci Transl Med; 2014 Nov; 6(261):261fs45. PubMed ID: 25378642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.
    Rao A; Vaught J; Tulskie B; Olson D; Odeh H; McLean J; Moore HM
    Biopreserv Biobank; 2019 Apr; 17(2):129-138. PubMed ID: 30638412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers.
    Somiari SB; Somiari RI
    Adv Exp Med Biol; 2015; 864():11-27. PubMed ID: 26420610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustainability in a Hospital-Based Biobank and University-Based DNA Biorepository: Strategic Roadmaps.
    Seiler CY; Eschbacher J; Bowser R; LaBaer J
    Biopreserv Biobank; 2015 Dec; 13(6):401-9. PubMed ID: 26697909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Academic Biobank Value and Sustainability Through an Outputs Focus.
    Rush A; Catchpoole DR; Ling R; Searles A; Watson PH; Byrne JA
    Value Health; 2020 Aug; 23(8):1072-1078. PubMed ID: 32828220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and Driving Forces for Business Plans in Biobanking.
    Macheiner T; Huppertz B; Bayer M; Sargsyan K
    Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
    Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
    Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organization of BBMRI.pl: The Polish Biobanking Network.
    Witoń M; Strapagiel D; Gleńska-Olender J; Chróścicka A; Ferdyn K; Skokowski J; Kalinowski L; Pawlikowski J; Marciniak B; Pasterk M; Matera-Witkiewicz A; Kozera Ł
    Biopreserv Biobank; 2017 Jun; 15(3):264-269. PubMed ID: 28103080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability.
    Uzarski D; Burke J; Turner B; Vroom J; Short N
    Clin Transl Sci; 2015 Oct; 8(5):553-7. PubMed ID: 25996355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.